Parkinson disease, dementia with Lewy bodies and multiple system atrophy are neurodegenerative disorders referred to as synucleinopathies. They are characterized by accumulation of alpha-synuclein (alpha-SN) as fibrillar inclusions in selectively vulnerable neurons and gila. Our understanding of the cellular mechanisms underlying the formation of alpha-SN inclusions and the toxicity of alpha-SN is poorly understood. In order to better understand the process of alpha-SN aggregation, our laboratory has used human neuronal [BE(2)-M17D] cells and the tetracycline-off (TetOff) inducible mechanism to generate cells overexpressing wild-type human alpha-SN. After 7 days of induction, sarkosyl-insoluble alpha-SN aggregates are detected in these cells. Exposure of our cell model to rotenone, a potent mitochondrial complex I inhibitor, led to the formation of RIPA buffer-insoluble, higher molecular weight sarkosyl-soluble alpha-SN species (consistent with oligomers) and sarkosyl-insoluble alpha-SN within five days. The oligomers were detected on Western blots as discrete bands containing truncated alpha-SN, and they exhibited no immunoreactivity with antibodies to alpha-SN phosphorylated at Ser129 or ubiquitin. Such oligomers, which were barely detectable in cells without rotenone treatment, may serve as seeds for alpha-SN polymerization or may be toxic to cells when they reach a critical concentration. In the studies proposed below, we plan to characterize alpha-SN oligomers further, focusing on determining (i) whether similar oligomers are produced in cells exposed to other neurotoxins relevant to PD and can be found in brains of familial and sporadic synucleinopathies, (ii) the mechanisms involved in their formation, and (iii) their role in alpha-SN assembly and neurotoxicity. In addition, we will determine (iv) whether overexpressing alpha-SN alters the gene expression profile in neuronal cells. These studies will contribute to our understanding of the formation of alpha-SN inclusions and their selective neurotoxicity for neurons.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS040256-09
Application #
7491432
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
9
Fiscal Year
2007
Total Cost
$295,826
Indirect Cost
Name
Mayo Clinic Jacksonville
Department
Type
DUNS #
153223151
City
Jacksonville
State
FL
Country
United States
Zip Code
32224
Verma, Manish; Callio, Jason; Otero, P Anthony et al. (2017) Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants. J Neurosci 37:11151-11165
Sanchez-Contreras, Monica; Heckman, Michael G; Tacik, Pawel et al. (2017) Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration. Mov Disord 32:115-123
Hassan, Anhar; Heckman, Michael G; Ahlskog, J E et al. (2016) Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms. Parkinsonism Relat Disord 22:102-5
Yue, M; Hinkle, K M; Davies, P et al. (2015) Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice. Neurobiol Dis 78:172-95
Cornejo-Olivas, Mario R; Torres, Luis; Mata, Ignacio F et al. (2015) A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics. Parkinsonism Relat Disord 21:444-8
Verma, Manish; Steer, Erin K; Chu, Charleen T (2014) ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease. Biochim Biophys Acta 1842:1273-81
Sundal, Christina; Fujioka, Shinsuke; Van Gerpen, Jay A et al. (2013) Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. Parkinsonism Relat Disord 19:869-77
Boeve, Bradley F (2013) Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease. Lancet Neurol 12:469-82
Foroutan, Parastou; Murray, Melissa E; Fujioka, Shinsuke et al. (2013) Progressive supranuclear palsy: high-field-strength MR microscopy in the human substantia nigra and globus pallidus. Radiology 266:280-8
Jiang, Peizhou; Gan, Ming; Ebrahim, Abdul Shukkur et al. (2013) Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of ýý-synuclein oligomers and decrease of neurites. Neurobiol Aging 34:1504-15

Showing the most recent 10 out of 205 publications